Even the score

New push to have FDA approve “Viagra for women”

LIU JIN/AFP/Getty Images

The FDA has already rejected the drug flibanserin, considered the female equivalent of Viagra, two times, but a new campaign, dubbed Even the Score, is underway that hopes the third time will be a charm. The movement is being led by Sprout Pharmaceuticals, the drug’s maker, and backed several women’s groups. An online petition has gather more than 40,000 signatures so far urging the drug’s approval and, on Thursday, the FDA will officially consider flibanserin for approval again. Many see the issue as a matter of gender equality. “Women have waited long enough. In 2015, gender equality should be the standard when it comes to access for treatments to sexual dysfunction,” a message on the movement’s website reads. But the FDA disputes that gender has played any role in its previous decisions. A spokesperson reportedly said the FDA “strongly rejects claims of gender bias” and pointed to a 2012 public workshop the agency held on drug development to treat the problem of sexual dysfunction in women. This time around, the FDA will have to decide if it will interpret some data on how the drug performed in testing differently than it has in the past.

Read the full story at The New York Times.

Leave a Reply

Your email address will not be published. Required fields are marked *